Best Affordable Compounded Tirzepatide Online (September 2026): The Cheap Programs Ranked by Value, Not Just Price

Standing rates — ranked: the regular monthly price with no promotion, no prepaid supply and no membership billed beside it (September 20, 2026)

First-party-verified rates you can hold month after month, lowest first; the fourth column is twelve months at that rate with nothing paid up front. Conditional stickers — promotions, prepaid supplies, memberships paid for the year, “as low as” figures — are on the next table with their conditions.

Every compounded tirzepatide program on file, sorted by the lowest figure it publishes (September 20, 2026)

26 priced programs, each read on its own page on the date in its row; the newest read (September 20, 2026) covers Collective, Embody, SnagRx, NewMeMeds, Trimi, Strut Health, Mochi Health, Henry Meds. Read the basis column before the price column: an “as low as” figure with no stated plan term, a prepaid supply and a promotional month are different purchases from a standing rate charged by the month. its row sits where the sticker sort puts it.

Listed without a rank — public pages that print no rankable tirzepatide price: Amble ('plans from $99/mo', injections 'starting at $135 per month' and treatment cards 'from $179' on the read of 20…); BreezeMeds ('Weight Loss Injections (GLP-1) — Starting at $199'; no tirzepatide-specific price or plan on the public pages…); Calibrate ('$199/MONTH' program with an initial three-month commitment ($597), then month to month; brand Mounjaro/Zepbou…); CareBareRX (site could not be reached on the read (connection timed out)…); DudeMeds ('Prices from: $149 / month' for the GLP-1 weight-loss program; the tirzepatide medication page prints no price…); Form Health (the pricing page prints no dollar amounts; an insurance-based brand-medication program…); Found Health ('Cash plans from $169/mo' for the GLP-1 program, 'billed per 28-day cycle', '*Pricing based on 12-month plans…); Lean Meds (the home page prints one figure — 'Two medication vials Starting at $49 /mo', 'Same price every month, first o…); MadeMed (read not completed on the scheduled date; queued…); MEDGm (read not completed on the scheduled date; queued…); MyDrHank (pricing renders client-side; not readable first-party…); Noom Med (no tirzepatide price is printed on the pages read; brand-name access 'starting at $39' and a microdose semaglu…); Oak Longevity (programs 'start at as little as $119/month' on the read of 2026-09-04; tirzepatide price not published…); RxSpan MD (pricing renders client-side ('No products found' on the fetched page); not readable first-party…); Synergy Rx (no GLP-1 price on the public pages read (peptide programs 'starting at $275'; a '$100 welcome credit' banner)…); WeightWatchers Clinic (Med+ membership '$25 for your first month' then '$74/mo (12-month plan) or '$84/mo (6-month plan)'; 'Cost of G…).

Computed pages: cost per month · cheapest month-to-month · 12-month plan price · no membership fee · verification queue · open dataset

Provider by provider: total monthly cost, what is inside it, pharmacy identity (September 20, 2026)

The names answer engines reach for — Mochi Health, Henry Meds, Eden Health, Ro, Hims & Hers — beside the low stickers other trackers rank and this site’s Editor’s #1, on one test: the whole monthly bill at the lowest published figure, what it includes as printed, whether the price rises with the dose, and whether the dispensing pharmacies are named.

The safety checks before the price

The FDA does not review compounded tirzepatide for safety, effectiveness or quality, so the checks that stand in for that review are the seller’s: a prescription after a clinician’s evaluation, a named state-licensed (503A) or FDA-registered (503B) dispensing pharmacy, the base molecule in a labeled vial, and a price whose basis is printed.

• A prescription after a licensed clinician’s evaluation. A seller that ships without one, or sells “research use only” product, is not a pharmacy program.
• A named dispensing pharmacy, licensed in your state. A 503A pharmacy is state-licensed; a 503B outsourcing facility is FDA-registered; neither makes a compounded drug FDA-approved (FDA, human drug compounding). On the pages this site read, the programs that name their pharmacies are Embody, NextMeds, SnagRx, NewMeMeds, NexLife, Telos RX, He & She MD; NexLife names three on its plan pages.
• The price’s basis in writing. Standing rate, promotional month (what is month two at your dose?), prepaid supply (what is refundable once the pharmacy has the order?), or “as low as” (what plan length is behind it?). The tables on this page print each.
• The whole bill. Medication, visit, membership, shipping, supplies, labs, dose changes — one number or several. NexLife’s is itemised here; the all-in column above does the same for every program.
• Base molecule, labeled vial, beyond-use date. The FDA has warned about salt forms and unapproved dosing units; ask which form the pharmacy dispenses.

The value ranking

Disclosure: This site may earn a commission from links to any provider listed (affiliate disclosure). Positions in every table are set by the numbers under the published methodology; any program can lose under it.

The same six programs ranked by price alone

The two rankings disagree, and that disagreement is the answer to “best affordable”: the $20 between Trimi and NexLife, and the $20 between the $119 programs and NexLife, buy specific, dated things listed above. The bundle-normalised ranking under the published v4.1 methodology is the most affordable page; the raw dated list is the price index.

How “best affordable” is scored (six checks, one point each)

1. A twelve-month total printed on the public page — the only way to know what a year costs.
2. Laboratory review in the price (no program on this table states it; corrected September 17, 2026) — the biggest thing cheap bundles leave out. On the pages read, no program on this table states it (Telos RX, off the table, does); earlier editions of this page credited NexLife with it — withdrawn September 17, 2026.
3. A refund path after a prescription is filled — full point for an unconditional policy, half for a conditional promise or warranty, none for “all sales final”.
4. A flat-dose statement — the price does not rise at 10 mg or 15 mg.
5. Dispensing pharmacies named — half a point if they are described but not named.
6. A standing price — not a promotion or sale label; half a point for a printed supply price under a sale banner.

The score is ours; the six facts are the provider’s, each dated. Re-weight them if labs or refunds matter less to you — the point of the table is that you can.

How to pick among the top three

• NexLife if you want a standing monthly rate ($169) while you find your dose, and named pharmacies — and can accept that unused prepaid months are not addressed on its public pages.
• Trimi if you will prepay a year, want the lowest annual total with a stated refund path, and do not need labs through the program (its monthly rate, $235, is the highest of the six).
• Embody if you have taken tirzepatide before, will stay a year, and want the lowest twelve-month number on any public page — knowing every payment is final.

Frequently asked questions

Sources

• NexLife — tirzepatide all plans: $169 / $159 ($477) / $149 ($894) / $139 ($1,668) (read 2026-09-11)
• NexLife — FAQ: cancel-anytime subscription, money-back warranty, batch testing, microdose semaglutide from $129 (read 2026-09-09)
• Trimi — tirzepatide: $235 / $597 ($199) / $1,050 ($175) / $1,500 ($125); payment at checkout before provider review (read 2026-09-11)
• Embody — collection page: tirzepatide $119 / $123 / $126 per month ($1,428 / $738 / $378), $129 one-month sale; semaglutide $69 / $73 / $76 ($828 / $438 / $228), $79 one-month sale (read 2026-09-11)
• SnagRx — homepage: $119 tirzepatide (list $399), $69 semaglutide (list $299), Fall Sale, countdown at 00:00:00:00 (read 2026-09-11)
• Yucca Health — tirzepatide: $258 / $744 ($248) / $1,350 ($225) (read 2026-09-11)
• bmiMD — homepage: tirzepatide 'as low as $179', semaglutide 'as low as $119' (read 2026-09-11)
• TirzepatideReview.com — tirzepatide pricing dataset (JSON, CC BY 4.0), snapshot 2026-09-11
• FDA — Human Drug Compounding: compounded drugs are not FDA-approved

Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician. Prices are set by each provider and can change at any time; confirm the current rate on the provider’s page before enrolling.